E.I. du Pont de Nemours & Co (DD)

78.65
NYSE : Basic Materials
Prev Close 78.29
Day Low/High 78.12 / 78.80
52 Wk Low/High 61.12 / 82.37
Avg Volume 2.89M
Exchange NYSE
Shares Outstanding 866.76M
Market Cap 67.86B
EPS 2.90
P/E Ratio 27.47
Div & Yield 1.52 (1.90%)

Latest News

Cramer: Are You Paying Attention to These Boring Companies? You Should

Cramer: Are You Paying Attention to These Boring Companies? You Should

We ought to open our eyes to what we don't care about, to what's still made here.

Cramer: Are You Paying Attention to These Boring Companies? You Should

Cramer: Are You Paying Attention to These Boring Companies? You Should

We ought to open our eyes to what we don't care about, to what's still made here.

Weekly Roundup

Syria missile strike and U.S. jobs report cap a rugged week for markets. We make several portfolio moves, including a downgrade.

EU Approves ChemChina's $43 billion Acquisition of Syngenta

EU Approves ChemChina's $43 billion Acquisition of Syngenta

ChemChina and Switzerland's Syngenta win conditional approval from the European Commission for their $43 billion Wednesday.

Where Does 'Oath' Rank Among the Worst Corporate Names?

Where Does 'Oath' Rank Among the Worst Corporate Names?

What were these places thinking?

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina Gets FTC OK to Snap Up Syngenta

ChemChina must sell its U.S. paraquat, abamectin and chlorothalonil crop protection businesses to California agrochemical company AMVAC.

Broker Darlings of the Dow: DuPont Ranks As a Top 15 Analyst Pick

Broker Darlings of the Dow: DuPont Ranks As a Top 15 Analyst Pick

A study of analyst recommendations at the major brokerages shows that DuPont is the #9 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. DuPont also comes in above the median of analyst picks among the broader S&P 500 index components, claiming the #176 spot out of 500.

Jim Cramer Is Watching Monsanto for Clues on Dow-DuPont Deal

Jim Cramer Is Watching Monsanto for Clues on Dow-DuPont Deal

Jim Cramer is watching Monsanto earnings, but for a read on its deal with Bayer rather than the actual results.

FMC Corp.: Cramer's Top Takeaways

FMC Corp.: Cramer's Top Takeaways

If investors liked FMC before the deal with DuPont, they should absolutely love it now, says Jim Cramer.

Profit-Taking Is Only Natural: Cramer's 'Mad Money' Recap (Monday 4/3/17)

Profit-Taking Is Only Natural: Cramer's 'Mad Money' Recap (Monday 4/3/17)

Jim Cramer says what's more noteworthy than the pullback is the day's strong rebound.

Jim Cramer on FMC's Purchase of DuPont's Pesticide Division

Jim Cramer on FMC's Purchase of DuPont's Pesticide Division

TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on FMC Corp.'s FMC purchase of DuPont's DD pesticide division.

Jim Cramer -- After DuPont Deal, FMC Can Go Higher

Jim Cramer -- After DuPont Deal, FMC Can Go Higher

After acquiring DuPont's crop-protection business, Jim Cramer says shares of FMC Corp. can still go higher.

Last Week's Portfolio Changes

We downgraded Apple, although we wouldn't want to alarm members.

Caterpillar, Allergan, Oclaro: Doug Kass' Views

Caterpillar, Allergan, Oclaro: Doug Kass' Views

Doug Kass shares his thoughts on Caterpillar, Allergan and Oclaro.

Getting It Done; Markets Love Seniors: Jim Cramer's Best Blog

Getting It Done; Markets Love Seniors: Jim Cramer's Best Blog

Jim Cramer ponders how Breen is getting it done for DuPont, and discusses why the markets love seniors so gosh darn much.

Stocks Post Strong First-Quarter Gains as Nasdaq Rockets 10%; Dow Jumps Nearly 5%

Stocks Post Strong First-Quarter Gains as Nasdaq Rockets 10%; Dow Jumps Nearly 5%

The Dow Jones Industrial Average ended the day and the month lower on Friday, but enjoyed a robust jump during the first three months of 2017.

Stocks Mixed Friday With an Eye on Gains for the First Quarter

Stocks Mixed Friday With an Eye on Gains for the First Quarter

Stocks are narrowly mixed on Friday as Wall Street looks to close out the first quarter with gains.

Cramer: Breen Is Getting It Done for DuPont

Cramer: Breen Is Getting It Done for DuPont

CEO's deal with FMC is a precursor to Dow merger.

Midday Report: Chicago PMI Ends Best Quarter Since 2014; Dow on Track for March Loss

Midday Report: Chicago PMI Ends Best Quarter Since 2014; Dow on Track for March Loss

The Dow Jones Industrial Average holds losses through the morning, even as the rest of the market pares lows or turns higher.

Dow Falls and Is on Track for First Monthly Loss Since Presidential Election

Dow Falls and Is on Track for First Monthly Loss Since Presidential Election

The Dow Jones Industrial Average is lower on Friday and remains on track to close out March with its first monthly loss since before the presidential election.

DuPont, Dow Take Another Step Toward Closing Their Merger

DuPont announced that it would sell a portion of its crop protection business to FMC Corp.

DuPont to Sell Part of Crop Business to FMC -- Jim Cramer Weighs in on Merger Implications

DuPont to Sell Part of Crop Business to FMC -- Jim Cramer Weighs in on Merger Implications

DuPont will also purchase FMC's health and nutrition unit, paving the way to closing its merger with Dow Chemical.

Stock Futures Slip as Wall Street Closes Out Mixed First Quarter

Stock Futures Slip as Wall Street Closes Out Mixed First Quarter

Stock futures move lower on Friday as Wall Street prepares to settle out the week, month and first quarter with mixed results.

Dow And DuPont Announce Amendments To Transaction Merger Agreement

Dow And DuPont Announce Amendments To Transaction Merger Agreement

- Dow and DuPont Amend Merger Agreement to Reflect Extension to August 31; Close of Transaction Now Expected No Earlier than August 1

DuPont Announces Agreement With FMC

DuPont Announces Agreement With FMC

- DuPont to Divest a Portion of Its Crop Protection Business and Acquire FMC's Health & Nutrition Business -

Picking Through the Portfolio

Updates on 4 stocks: Dow, Alphabet, Magellan and Schlumberger.

Why Jim Cramer Is Bullish on Dow Chemical

Why Jim Cramer Is Bullish on Dow Chemical

TheStreet's Jim Cramer is very happy with his charitable trust's position in Dow Chemical DOW, which received approval from the European Commission to merge with DuPont DD.